#LCSM Chat Topic 09/19/19: World Lung (#WCLC19) Wrap-Up

Please join the #lcsm community and moderator Brendon Stiles (@BrendonStilesMD) for our next #LCSM Chat on Thursday, September 19th, 2019, at 8 pm Eastern Time (5 pm Pacific). Clinicians, researchers, patients and advocates from all over the world attended the 2019 World Conference on Lung Cancer (#WCLC19) from September 7-10 in Barcelona.  This annual event, hosted by the International Association for the Study of Lung Cancer (IASLC), is a showcase for all of the latest news and advances in lung cancer.  The meeting is somewhat unique in that it is multidisciplinary in… Read More

#LCSM Chat Topic 05/09/2019: What’s new in early stage lung cancer

Our May 9, 2019 #LCSM Chat at 8 pm Eastern (5 pm Pacific) will focus on the newest treatments for early stage lung cancer. The topic should be interesting to all who deal with early stage disease — patients, caregivers, oncology nurses, surgeons, radiologists, pulmonologists, pathologists, and oncologists. Although we have all heard about the tremendous advances in the treatment of metastatic lung cancer, we sometimes don’t appreciate the incredible progress we have also made in diagnosing and treating early stage lung cancer. Early stage patients can realistically strive for and expect… Read More

#LCSM Chat Topic 03/07: Biomarker Magicians (or, Why We Love Pathologists)

Diagnosing the type of lung cancer from a tissue or liquid biopsy is absolutely critical to selecting treatment and determining the patient’s prognosis. However, for many lung cancer patients and their families, the role of tumor tissue in their diagnosis is a mystery. What happens to tissue collected in a biopsy? How is it analyzed? What is involved in getting helpful answers from biomarker testing? The specialized doctors responsible for answering these questions are pathologists.  They identify any lung cancer cells in the biopsied tissue, and guide the patient’s biomarker testing. Unfortunately,… Read More